Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Abivax

- PMLiVE

Abivax has appointed Ivan Nuñez-Pacheco as Abivax Global Head of Patient Services

Nuñez-Pacheco most recently served as Senior Director of AbbVie Patient Services

- PMLiVE

Abivax has appointed James Berger as Global Head of Marketing

Berger previously served in senior leadership roles at Amgen and Takeda

- PMLiVE

Abivax shares positive late-stage results for obefazimod in ulcerative colitis

Inflammatory bowel disease affects nearly one in every 100 people in the US

- PMLiVE

Abivax enrols first patient in global phase 3 programme with obefazimod in ulcerative colitis

So far, more than 460 study sites have been qualified to take part in the phase 3 trials

- PMLiVE

Abivax’s COVID-19 study declared Research National Priority by French government

Drug treatment is being investigated in high-risk COVID-19 patients

- PMLiVE

Abivax doses first patient in phase 2b/3 COVID-19 clinical trial

Study will evaluate experimental anti-inflammatory drug

- PMLiVE

Trial data suggest Abivax’ drug may clear latent HIV

The drug reduced HIV DNA in cells over 28 days

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links